MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series A
TheraSolve NV
Parents
*Architects: Telemedicine (Medication Therapy Management [MTM], Adherence & Chronic Disease Management)
Industry: Belgium
Venture Capital: Series A
Children
Diepenbeek (Belgium)
First financing round co-led by Thuja Capital and LRM. Read more: TheraSolve NV closes first financing round to develop innovative treatment adherence solution MemoPatch - FierceMedicalDevices http://www.fiercemedicaldevices.com/press-releases/therasolve-
The management team consists of Wim De Geest, MSc (CEO), Jan De Geest, MSc (CTO) and Ivo Abraham, PhD (CSO).
TheraSolve is developing MemoPatch, a disposable device that reminds patients to take their medications - discreetly, wherever they may be, and whatever they may be doing.
TheraSolve NV closes first financing round to develop innovative treatment adherence solution MemoPatch (2011)
TheraSolve will be able to develop and initiate commercialization of its innovative MemoPatch device to enhance treatment adherence. Read more: TheraSolve NV closes first financing round to develop innovative treatment adherence solution MemoPatch